apitegromab tirzepatide A new phase 2 trial in Nature Medicine tested whether apitegromab, an investigational monoclonal antibody that selectively inhibits myostatin activation, could preserve lean mass during… Very nice summary and infographic

Discomfort more often arises from the medication entering the tissue, which can create a sensation of pressure or mild burning that typically resolves within seconds

In one clinical study, CJC-1295 produced dose-dependent increases in GH for six days or more and IGF-1 increases for nine to eleven days after a single administration

PlexusDx provides personalized tirzepatide therapy with dosing tailored to your genetic and physiological needs

Future trials should report age- and disease-stratified data to better clarify whether patient-specific factors, such as diabetes, influence tolerability and safety profiles

There is no such thing as a safe tan, as any tan is a sign of skin damage